Recent studies have shown that glioblastomas contain aberrations largely in genes involved in Rb, p53 and receptor tyrosine kinase (RTK)/Ras/phosphatidylinositol-3-kinase (PI3K) signaling pathways [6, 7]. This evidence concerns the gene RB1 and glioblastoma.